PARNAXLAB — Parnax Lab Balance Sheet
0.000.00%
- IN₹1.19bn
- IN₹2.00bn
- IN₹2.49bn
Annual balance sheet for Parnax Lab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | — | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 57.8 | 12.8 | 4.58 | 5.5 | 3.36 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 393 | 314 | 400 | 350 | 499 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 748 | 611 | 769 | 683 | 930 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 752 | 789 | 1,093 | 1,169 | 1,253 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,535 | 1,451 | 1,903 | 1,898 | 2,276 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 810 | 630 | 833 | 743 | 958 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,053 | 829 | 1,187 | 1,067 | 1,325 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 482 | 622 | 716 | 831 | 951 |
| Total Liabilities & Shareholders' Equity | 1,535 | 1,451 | 1,903 | 1,898 | 2,276 |
| Total Common Shares Outstanding |